Display options
Cite
Hayes JR, Jewett MA, Hamilton RJ. 28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically. Can Urol Assoc J. 2016;10(7):E257-E260doi: 10.5489/cuaj.3492.
Hayes, J. R., Jewett, M. A., & Hamilton, R. J. (2016). 28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10(7), E257-E260. https://doi.org/10.5489/cuaj.3492
Hayes, James R, et al. "28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 10,7 (2016): E257-E260. doi: https://doi.org/10.5489/cuaj.3492
Hayes JR, Jewett MA, Hamilton RJ. 28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically. Can Urol Assoc J. 2016 Jul-Aug;10(7):E257-E260. doi: 10.5489/cuaj.3492. Epub 2016 Jul 12. PMID: 28255418; PMCID: PMC5325756.
Copy Download .nbib Format: NLM
Share it on

Can Urol Assoc J. 2016 Jul-Aug;10(7):E257-E260. doi: 10.5489/cuaj.3492. Epub 2016 Jul 12.

28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

James R Hayes, Michael A S Jewett, Robert J Hamilton

Affiliations

  1. Department of Surgical Oncology (Urology), Princess Margaret Cancer Centre, Toronto, ON, Canada.

PMID: 28255418 PMCID: PMC5325756 DOI: 10.5489/cuaj.3492

Abstract

We present a patient who relapsed symptomatically 28 years post-orchiectomy, initially followed by active surveillance for clinical stage I non-seminomatous germ cell tumour (CSI NSGCT). His relapse was localized to the pelvis, managed with robotic surgery, and achieved a complete resection with tumour markers normalized. We highlight the current Princess Margaret guidelines for followup of CSI NSGCT and discuss the trade-off between lifelong radiographic surveillance to detect the very small risk of late relapse. We discuss the incidence and presentation of late relapse, treatment options, and outcomes, highlighting that these tumours are typically refractory to chemotherapy and can often be managed with surgery alone.

References

  1. BJU Int. 2015 Dec;116(6):920-3 - PubMed
  2. Ann R Coll Surg Engl. 2011 Jul;93(5):e24-6 - PubMed
  3. Curr Urol Rep. 2013 Oct;14(5):518-24 - PubMed
  4. J Clin Oncol. 2008 Dec 1;26(34):5647-8 - PubMed
  5. Urol Clin North Am. 2015 Aug;42(3):359-68 - PubMed
  6. J Clin Oncol. 2005 Oct 1;23(28):6999-7004 - PubMed
  7. J Clin Oncol. 2015 Jan 1;33(1):51-7 - PubMed
  8. J Clin Oncol. 2014 Dec 1;32(34):3817-23 - PubMed
  9. Eur Urol. 2011 Dec;60(6):1299-302 - PubMed
  10. J Urol. 1999 Feb;161(2):472-5; discussion 475-6 - PubMed
  11. Urology. 2006 Apr;67(4):846.e11-3 - PubMed
  12. Can Urol Assoc J. 2010 Apr;4(2):e19-38 - PubMed
  13. J Clin Oncol. 2003 Jan 1;21(1):113-22 - PubMed
  14. Eur Urol. 2011 Apr;59(4):556-62 - PubMed
  15. J Clin Oncol. 1992 Nov;10(11):1762-8 - PubMed
  16. Semin Urol. 1984 Nov;2(4):204-7 - PubMed
  17. Crit Rev Oncol Hematol. 2007 Dec;64(3):182-97 - PubMed

Publication Types